vs
Side-by-side financial comparison of CHIMERA INVESTMENT CORP (CIM) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $66.2M, roughly 1.3× CHIMERA INVESTMENT CORP). CHIMERA INVESTMENT CORP runs the higher net margin — 42.8% vs 22.8%, a 20.0% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 0.5%). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 0.8%).
Chimera Investment Corp is a US-based real estate investment trust (REIT) primarily investing in residential mortgage-backed securities, residential and commercial mortgage loans, and other real estate-related financial assets. It delivers sustainable risk-adjusted returns for shareholders via regular dividend distributions from its investment portfolio.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
CIM vs FDMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $66.2M | $85.1M |
| Net Profit | $28.3M | $19.4M |
| Gross Margin | — | — |
| Operating Margin | 42.6% | 17.3% |
| Net Margin | 42.8% | 22.8% |
| Revenue YoY | 0.5% | 8508900.0% |
| Net Profit YoY | 119.3% | 139.1% |
| EPS (diluted) | $0.05 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $66.2M | $85.1M | ||
| Q3 25 | $65.0M | $90.0K | ||
| Q2 25 | $66.0M | $15.0K | ||
| Q1 25 | $69.2M | $14.0K | ||
| Q4 24 | $65.8M | $1.0K | ||
| Q3 24 | $66.5M | $3.0K | ||
| Q2 24 | $67.3M | $5.0K | ||
| Q1 24 | $65.1M | $28.0K |
| Q4 25 | $28.3M | $19.4M | ||
| Q3 25 | $-580.0K | $-56.9M | ||
| Q2 25 | $35.5M | $-54.7M | ||
| Q1 25 | $167.3M | $-48.0M | ||
| Q4 24 | $-146.5M | — | ||
| Q3 24 | $136.5M | $-43.8M | ||
| Q2 24 | $56.7M | $-35.0M | ||
| Q1 24 | $129.5M | $-32.4M |
| Q4 25 | 42.6% | 17.3% | ||
| Q3 25 | -0.5% | -67983.3% | ||
| Q2 25 | 54.3% | -396373.3% | ||
| Q1 25 | — | -383007.1% | ||
| Q4 24 | -222.6% | — | ||
| Q3 24 | — | -1704400.0% | ||
| Q2 24 | 84.2% | -849120.0% | ||
| Q1 24 | — | -136200.0% |
| Q4 25 | 42.8% | 22.8% | ||
| Q3 25 | -0.9% | -63195.6% | ||
| Q2 25 | 53.7% | -364386.7% | ||
| Q1 25 | 241.7% | -342657.1% | ||
| Q4 24 | -222.6% | — | ||
| Q3 24 | 205.4% | -1461433.3% | ||
| Q2 24 | 84.2% | -699060.0% | ||
| Q1 24 | 198.8% | -115717.9% |
| Q4 25 | $0.05 | $0.43 | ||
| Q3 25 | $-0.27 | $-1.01 | ||
| Q2 25 | $0.17 | $-0.98 | ||
| Q1 25 | $1.77 | $-0.86 | ||
| Q4 24 | $-2.06 | — | ||
| Q3 24 | $1.39 | $-0.79 | ||
| Q2 24 | $0.41 | $-0.63 | ||
| Q1 24 | $1.36 | $-0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $278.6M | $402.7M |
| Total DebtLower is stronger | $251.5M | — |
| Stockholders' EquityBook value | $2.6B | $505.7M |
| Total Assets | $15.8B | $566.7M |
| Debt / EquityLower = less leverage | 0.10× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $278.6M | $402.7M | ||
| Q3 25 | $491.5M | $305.1M | ||
| Q2 25 | $250.2M | $293.2M | ||
| Q1 25 | $253.3M | $321.4M | ||
| Q4 24 | $84.0M | $424.9M | ||
| Q3 24 | $97.3M | $501.9M | ||
| Q2 24 | $162.3M | $541.9M | ||
| Q1 24 | $169.0M | $525.9M |
| Q4 25 | $251.5M | — | ||
| Q3 25 | $251.0M | — | ||
| Q2 25 | $135.2M | — | ||
| Q1 25 | $134.9M | — | ||
| Q4 24 | $134.6M | — | ||
| Q3 24 | $134.4M | — | ||
| Q2 24 | $62.4M | — | ||
| Q1 24 | — | — |
| Q4 25 | $2.6B | $505.7M | ||
| Q3 25 | $2.6B | $369.0M | ||
| Q2 25 | $2.6B | $420.9M | ||
| Q1 25 | $2.6B | $469.7M | ||
| Q4 24 | $2.5B | $510.6M | ||
| Q3 24 | $2.7B | $552.9M | ||
| Q2 24 | $2.6B | $588.3M | ||
| Q1 24 | $2.6B | $600.6M |
| Q4 25 | $15.8B | $566.7M | ||
| Q3 25 | $15.1B | $424.0M | ||
| Q2 25 | $14.9B | $473.6M | ||
| Q1 25 | $13.2B | $515.7M | ||
| Q4 24 | $13.1B | $560.4M | ||
| Q3 24 | $13.7B | $604.0M | ||
| Q2 24 | $13.1B | $620.1M | ||
| Q1 24 | $12.5B | $629.9M |
| Q4 25 | 0.10× | — | ||
| Q3 25 | 0.10× | — | ||
| Q2 25 | 0.05× | — | ||
| Q1 25 | 0.05× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.05× | — | ||
| Q2 24 | 0.02× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-248.9M | $28.6M |
| Free Cash FlowOCF − Capex | — | $28.5M |
| FCF MarginFCF / Revenue | — | 33.5% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | -8.78× | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-248.9M | $28.6M | ||
| Q3 25 | $-137.5M | $-46.5M | ||
| Q2 25 | $-7.4M | $-43.4M | ||
| Q1 25 | $48.8M | $-47.8M | ||
| Q4 24 | $205.7M | $-134.6M | ||
| Q3 24 | $41.4M | $-29.4M | ||
| Q2 24 | $69.0M | $-30.2M | ||
| Q1 24 | $57.3M | $-29.1M |
| Q4 25 | — | $28.5M | ||
| Q3 25 | — | $-46.6M | ||
| Q2 25 | — | $-43.4M | ||
| Q1 25 | — | $-48.4M | ||
| Q4 24 | — | $-138.4M | ||
| Q3 24 | — | $-31.2M | ||
| Q2 24 | — | $-30.6M | ||
| Q1 24 | — | $-29.8M |
| Q4 25 | — | 33.5% | ||
| Q3 25 | — | -51765.6% | ||
| Q2 25 | — | -289620.0% | ||
| Q1 25 | — | -345635.7% | ||
| Q4 24 | — | -13837100.0% | ||
| Q3 24 | — | -1038966.7% | ||
| Q2 24 | — | -611840.0% | ||
| Q1 24 | — | -106421.4% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 101.1% | ||
| Q2 25 | — | 440.0% | ||
| Q1 25 | — | 4507.1% | ||
| Q4 24 | — | 378600.0% | ||
| Q3 24 | — | 59266.7% | ||
| Q2 24 | — | 6980.0% | ||
| Q1 24 | — | 2535.7% |
| Q4 25 | -8.78× | 1.47× | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.21× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.30× | — | ||
| Q2 24 | 1.22× | — | ||
| Q1 24 | 0.44× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
